Drugs / DIMETHYLCURCUMIN
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01289574 | Feb 2011 → Jul 2012 | acne | AndroScience Corp | Completed | Missed primary |
| Phase 2 | NCT00525499 | Aug 2007 → Apr 2008 | acne | AndroScience Corp | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DIMETHYLCURCUMIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL128748 ↗ |
| Known as | ASC-J9 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00525499 ↗ |
| Known as | CHC-004 | ChEMBL registry synonym — accepted as the source's own label CHEMBL128748 ↗ |
| Known as | GO-Y-025 | ChEMBL registry synonym — accepted as the source's own label CHEMBL128748 ↗ |
| Action | Deplete | “Androgen Receptor degrader” CHEMBL128748 ↗ |
| Modality | Small molecule | — CHEMBL128748 ↗ |
| Route | Topical | “Topical application to the face twice daily for 12 weeks.” NCT00525499 ↗ |
| Target | AR | “Androgen Receptor degrader” CHEMBL128748 ↗ |